Ampio Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q1 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Ampio Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q3 2022.
  • Ampio Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2022 was $347K, a 31.9% increase year-over-year.
  • Ampio Pharmaceuticals, Inc. Depreciation for the twelve months ending September 30, 2022 was $1.13M.
  • Ampio Pharmaceuticals, Inc. annual Depreciation for 2021 was $1.09M, a 7.05% decline from 2020.
  • Ampio Pharmaceuticals, Inc. annual Depreciation for 2020 was $1.18M, a 7.47% decline from 2019.
  • Ampio Pharmaceuticals, Inc. annual Depreciation for 2019 was $1.27M, a 0.7% decline from 2018.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $1.13M $347K +$84K +31.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.04M $256K -$18K -6.57% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.06M $262K -$32K -10.9% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $1.09M $263K Oct 1, 2021 Dec 31, 2021 10-K 2022-03-29
Q3 2021 $263K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $274K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $294K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.